FDA approves new rapid-acting insulin with a novel delivery method
The FDA approved a new therapy last week to improve blood sugar control in patients with diabetes — primarily type 1 (insulin-dependent). The drug, Afrezza, is a novel short acting insulin formulation...
View ArticleConsuming a diet based on glycemic index may not improve cardiovascular risk...
The glycemic index (GI) is a number supposedly corresponding to a carbohydrate-containing food’s effect on blood glucose levels. A food with a low GI value (dried apricots, steel cut oats) has less...
View ArticleEarly trial for type 1 diabetes vaccine shows promise
Type 1 diabetes, previously known as juvenile diabetes, affects approximately 1.25 million American children and (much less commonly) adults. Unlike the much more common type 2 diabetes, which is...
View ArticleInsulin Pill Could Revolutionize Diabetes Treatment
The holy grail of diabetes research has long been finding a way to administer insulin by mouth. And that goal may have been reached by scientists at the University of California at Santa Barbara, who...
View ArticleInsulin Over the Counter: Available, but Risky
What if a diabetes sufferer, who needs insulin to manage the condition, loses their insurance or can't afford the co-pays. It is possible to buy the drug instead, without a prescription and over the...
View ArticleInvention Allows Transplanted Cells to Evade Immune System
The human body's immune system is similar to having millions, if not billions, of snipers at the ready – aiming and poised to shoot any foreign invader. This is why transplanted tissues and organs are...
View Article
